Streetbeat News

Analyst Ratings

DIN

Analysts have provided various ratings for Dine Brands Global (NYSE:DIN) in the last quarter, with 2 bullish, 2 somewhat bullish, and 4 indifferent. The company has an average 12-month price target of $68.38, a decrease of 17.12% from the previous average price target of $82.50.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 12:00 pm

CABA

In the last quarter, Cabaletta Bio (NASDAQ:CABA) received 4 bullish ratings from analysts. The company has an average 12-month price target of $26.75, with a high of $34.00 and a low of $17.00. The average price target has increased by 78.33% over the past month.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 12:00 pm

OLN

Olin (NYSE:OLN) has received various analyst ratings in the last quarter, with 1 bullish, 7 somewhat bullish, 1 indifferent, and 3 somewhat bearish. The average 12-month price target for Olin is $60.25, a decrease of 3.82% from the previous average price target of $62.64.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 12:00 pm

FOXA

Analysts have provided various ratings for Fox (NASDAQ:FOXA) within the last quarter, with most being indifferent. The average price target is $36.0, implying an upside from the current price of $30.98. The average price target has increased by 0.93% over the past month.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 12:00 pm

CTVA

Over the last quarter, Corteva (NYSE:CTVA) has received 12 bullish analyst ratings with an average 12-month price target of $70.08, a 1.45% decrease from the previous average price target of $71.11.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 12:00 pm

WWD

Over the past 3 months, 8 analysts have published their opinion on Woodward (NASDAQ:WWD) stock. The average price target is $122.5, which is lower than the current price of $129.85. The current average has increased by 13.43% from the previous average price target of $108.00.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 12:00 pm

MDGL

B. Riley Securities analyst Mayank Mamtani has reiterated a Neutral rating on Madrigal Pharmaceuticals (NASDAQ:MDGL) and maintained a price target of $224.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 11:59 am

FEAM

B. Riley Securities analyst Matthew Keating maintains a 'Buy' rating on 5E Advanced Materials (NASDAQ:FEAM), but has lowered the price target from $10 to $5.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 11:59 am

DHC

B. Riley Securities analyst Bryan Maher maintains a Buy rating on Diversified Healthcare (NASDAQ:DHC) and raises the price target from $4 to $4.5.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 11:58 am

RSI

JMP Securities analyst Jordan Bender has reiterated a Market Outperform rating on Rush Street Interactive (NYSE:RSI) and maintained a $7 price target.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 11:56 am